Prezcobix and Loraz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prezcobix and Loraz. Common interactions include pain among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people who take Prezcobix and Loraz have. It is created by eHealthMe based on reports of 29 people who take Prezcobix and Loraz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

29 people who take Prezcobix and Loraz together, and have interactions are studied.


What is Prezcobix?

Prezcobix has active ingredients of cobicistat; darunavir ethanolate. eHealthMe is studying from 1,625 Prezcobix users for its effectiveness, alternative drugs and more.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 145,051 Loraz users for its effectiveness, alternative drugs and more.

Number of Prezcobix and Loraz reports submitted per year:

Prezcobix and Loraz drug interactions.

Common Prezcobix and Loraz drug interactions by gender *:

female:

  1. Pain
  2. Emotional distress
  3. Fracture
  4. Osteoporosis
  5. Anhedonia
  6. Bone density decreased
  7. Gait disturbance
  8. Renal failure
  9. Arthralgia
  10. Chronic kidney disease

male:

  1. Emotional distress
  2. Pain
  3. Decreased activity
  4. Diabetes mellitus
  5. Impaired work ability
  6. Metabolic acidosis
  7. Nephrolithiasis
  8. Renal transplant
  9. Tooth loss
  10. Bone density decreased

Common Prezcobix and Loraz drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pain
  2. Emotional distress
  3. Gait disturbance
  4. Anhedonia
  5. Fatigue
  6. Fracture
  7. Osteoporosis
  8. Quality of life decreased
  9. Bone density decreased
  10. Hip fracture

40-49:

  1. Emotional distress
  2. Pain
  3. Anhedonia
  4. Renal failure
  5. Renal impairment
  6. Azotaemia
  7. Chronic kidney disease
  8. Decreased activity
  9. Diabetes mellitus
  10. Hyperkalaemia

50-59:

  1. Renal failure
  2. Anhedonia
  3. Bone density decreased
  4. Emotional distress
  5. Multiple fractures
  6. Pain

60+:

  1. Cd4 lymphocytes decreased
  2. Haemoglobin decreased
  3. Platelet count decreased
  4. T-lymphocyte count decreased
  5. White blood cell count decreased

Common conditions people have *:

  1. Hiv Infection: 28 people, 96.55%
  2. High Blood Pressure: 4 people, 13.79%
  3. High Blood Cholesterol: 4 people, 13.79%
  4. Procedural Pain: 3 people, 10.34%
  5. Infection: 3 people, 10.34%
  6. Diabetes: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Prezcobix and Loraz?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Prezcobix and Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prezcobix interactions:

Browse all interactions between Prezcobix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Loraz interactions:

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; darunavir ethanolate and lorazepam (the active ingredients of Prezcobix and Loraz, respectively), and Prezcobix and Loraz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Prezcobix and Loraz.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: